Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7484 p3-10
5/12 January 2008

This section
Reprint   Photocopy

PDF 210K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages:  3     4     5     6     7     8     9    10 

3 Antimicrobial pharmacist funding boost announced Every hospital trust in England will be able to fund an antimicrobial pharmacist post following allocation of £270m a year to support infection control in the NHS
PJ 2007;279:3
Full Text

3 Pharmacy staff key in safe transfer of patients during Marsden blaze Pharmacy staff played an important part in the care of patients who were transferred to the Royal Brompton Hospital, London, following last week’s fire at the neighbouring Royal Marsden Hospital
PJ 2007;279:3
Full Text

3 Launch of internet pharmacy logo to help protect consumers Legitimate online pharmacies received a boost this week with the launch of an authorised internet pharmacy logo by the Royal Pharmaceutical Society
PJ 2007;279:3
Full Text

3 Two pharmacists recognised in New Year honours list Two pharmacists received honours in this year’s New Year honours list
PJ 2007;279:3
Full Text



4 PM pledges to strengthen screening and prevention Screening, prevention and strengthened commissioning are to be the basis of continuing reform of the NHS in England, Prime Minister Gordon Brown stated this week
PJ 2007;279:4
Full Text

4 Changes to NICE procedures recommended by Health Committee All medicines should be assessed at launch by the National Institute for Health and Clinical Excellence, the Health Committee recommended this week
PJ 2007;279:4
Full Text

4 Government seeks 10 per cent cut in drug prices in new PPRS agreement, FT reports Savings of 10 per cent in the prices the NHS pays for drugs are being sought by the Government, Health Secretary Alan Johnson revealed in an interview in the Financial Timesthis week
PJ 2007;279:4
Full Text

4 Society’s new Disciplinary Committee takes over reins from the Statutory Committee Responsibility for the professional discipline of pharmacists has now passed from the Royal Pharmaceutical Society’s Statutory Committee to its new Disciplinary Committee
PJ 2007;279:4
Full Text



5 Technicians in Scotland to be registered by Society Pharmacy technicians in Scotland will soon be able to register with the Royal Pharmaceutical Society
PJ 2007;279:5
Full Text

5 Scottish Government publishes guidance on pharmacist independent prescribing Guidance on independent prescribing by pharmacists in Scotland was published last week
PJ 2007;279:5
Full Text

5 Your Society launched The first issue of Your Society — a monthly newsletter updating members of the Royal Pharmaceutical Society on its services, personalities and future developments — is distributed with this issue of The Journal
PJ 2007;279:5
Full Text



6 MPs call for brand-only prescribing for biotech drugs Medicines derived through biotechnology should always be prescribed by brand, rather than by their generic name, a review by a Parliamentary panel published this week has recommended
PJ 2007;279:6
Full Text

6 Planned stoma/appliance fees “inadequate” Fees proposed by the Government for stoma and incontinence services are inadequate and unrealistic, pharmacy bodies have warned
PJ 2007;279:6
Full Text

6 Voluntary regulation planned for complementary therapies Practitioners of alternative therapies will be able to register with a new regulator — the Natural Healthcare Council — that is to be launched in April 2008
PJ 2007;279:6
Full Text

6 Neuropathic pain study Dihydrocodeine provides better neuropathic pain relief than the synthetic cannabinoid nabilone, according to a study published online. The authors admit that the clinical significance of the difference is small and neither drug was particularly effective
PJ 2007;279:6
Full Text



7 Europe’s public supports further development of community pharmacy services to widen choice Substantial public support exists for the further development of community pharmacies as alternatives to doctors’ surgeries, according to a report published last month
PJ 2007;279:7
Full Text



8 Community pharmacists must not miss the boat with commissioning Community pharmacists should not see practice-based commissioning (PBC) as a passing policy or they are in danger of being left behind. This is the conclusion of a new guide on PBC for community pharmacy contractors published by the Pharmaceutical Services Negotiating Committee this week
PJ 2007;279:8
Full Text

8 Scottish CD regulations to come into force on 1 February Changes to record keeping requirements for Controlled Drugs will come into force in Scotland on 1 February 2008. Guidance on these requirements was published by the Scottish Government at the end of December 2007
PJ 2007;279:8
Full Text

8 Numark appoints interim head John D’Arcy, who recently moved to Phoenix from the National Pharmacy Association, has been appointed interim managing director of Numark following the death of Simon Colebeck
PJ 2007;279:8
Full Text

8 Roll-out of Pharmasys authorised National roll-out of Pharmasys, Swebtec’s electronic prescription service release 1-compliant system, has been authorised by NHS Connecting for Health
PJ 2007;279:8
Full Text

8 Influenza threshold reached Influenza reports in England and Wales have exceeded the threshold at which the National Institute for Health and Clinical Excellence guidelines on the use of antivirals are triggered, the Department of Health has announced
PJ 2007;279:8
Full Text



9 NPA stays silent over rumours about its CE The National Pharmacy Association may be about to lose its second chief executive in less than a year
PJ 2007;279:9
Full Text

9 Pharmacy graduates motivated by career and promotion prospects Career and promotion prospects are the major motivators for pharmacy graduates when they choose their preregistration training posts
PJ 2007;279:9
Full Text



10 New pseudoephedrine sales restrictions confirmed Tightened restrictions on counter sales of products that contain pseudoephedrine or ephedrine have been confirmed by the Medicines and Healthcare products Regulatory Agency
PJ 2007;279:10
Full Text

10 Don’t always treat fungal infections, says DTB Fungal nail infections do not necessarily warrant treatment, the Drug and Therapeutics Bulletin has concluded
PJ 2007;279:10
Full Text

10 DTB endorses eplerenone Eplerenone treatment three to 14 days after a myocardial infarction can reduce death and disease in patients who develop left ventricular systolic dysfunction (LVDS) complicated by heart failure, the Drug and Therapeutics Bulletin has concluded
PJ 2007;279:10
Full Text

10 MHRA warns about interactions with statins Updated prescribing advice for atorvastatin, including new dose restrictions when it is given with clarithromycin, itraconazole and ciclosporin, is issued in the latest Drug Safety Update published by the Medicines and Healthcare products Regulatory Agency
PJ 2007;279:10
Full Text

10 PPIs drain drug budgets Inappropriate prescribing of proton pump inhibitors is draining drugs budgets, a BMJ editorial argues
PJ 2007;279:10
Full Text

10 Paclitaxel combination Treating metastatic breast cancer with paclitaxel plus bevacizumab prolongs progression-free survival, but not overall survival, compared with paclitaxel alone, according to a study
PJ 2007;279:10
Full Text

Back to Top


©The Pharmaceutical Journal